PlocamiumAI develops AI-driven precision medicine solutions for oncology and movement disorders. The startup appears in healthcare and life sciences deal coverage but lacks recent public signals or disclosed funding details.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edits, or content requests — sent directly to James.